I believe the current cost of yearly treatment with Pulmozyme is...

I believe the current cost of yearly treatment with Pulmozyme is around $22,000 usd if my memory serves me right, it was mentioned in one of the investor briefing conference calls.

So, it is possible once we receive approval that the price of Bronchitol may be at the higher end of what we were all thinking, it could even be up around $18,000-$20,000 usd.

Even though it is sometime off, a 15% uptake by the world's 75000 CF sufferers could mean revenue of 202 Mil or higher.

With an approval for Bronchiectasis possible in the next few years, well the sky's the limit really if all the planets align!